16:08 EDT Lixte Biotechnology (LIXT) files to sell 467,393 shares of common stock for holders
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LIXT:
- Lixte Biotechnology launches new study in collaboration with NKI on LB-100
- Lixte Biotechnology provides update on progress with LB-100
- Lixte announces online publication of new pre-clinical data in BioXriv
- Lixte Biotechnology adds Lurie Cancer Center as second site in LB-100 trial
- Lixte Biotechnology announces closing of $1.05M registered direct offering